Barbara Klencke – Biography
Last update: March 27, 2026Executive profile
Barbara was Director at Effector Therapeutics, and Chief Medical Officer and Chief Development Officer at Sierra Oncology. Barbara Klencke joined Immune-Onc Therapeutics in 2025.
Barbara Klencke is currentlyChief Medical Officer at ALX Oncology - View - ALX Oncology org chart
Director at Immune-Onc Therapeutics - View - Immune-Onc Therapeutics org chart
Director at TScan Therapeutics - View - TScan Therapeutics org chart
Director at Xencor - View - Xencor org chart
Create your alert
to follow the career of Barbara Klencke.
Education
In 1990, Barbara Klencke completed a Doctor of Medicine in Medicine at University of California at Davis.
They have also studied at University of California at Davis :
Find more alumni from University of California at Davis
More about Barbara Klencke
Selected links
Do you need to know more about Barbara Klencke? More results.
Participate
Social media
- Barbara Klencke on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Barbara Klencke
The colleagues of Barbara Klencke
Company Colleagues
- At ALX Oncology, Barbara Klencke has 19 colleagues including Jason Lettmann (CEO), Rekha Hemrajani (Director)…
- At Immune-Onc Therapeutics, Barbara Klencke has 9 colleagues including Charlene Liao (CEO & Director), Dave Chenn (Director)…
- At TScan Therapeutics, Barbara Klencke has 19 colleagues including Gavin MacBeath (CEO & Director), Gabriela Gruia (Director)…
- At Xencor, Barbara Klencke has 17 colleagues including Bassil Dahiyat (CEO & Director), Kevin Gorman (Director)…
Industry Colleagues
- In the Biotechnology industry, Barbara Klencke has 35,763 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Barbara Klencke.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Barbara Klencke.
